Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...
Enhances B Cell Responses in Type 2 Inflammation Through IL-17RB Receptor,” published in the January 2025 issue of Allergy ...
SANG W. LEE PROCTOLOGY Clinical Professor; Chief, Colon and Rectal Surgery Keck Medicine of USC Dr. Sang Lee is one of the nation’s leading experts in ...
(Alliance News) - GSK PLC on Tuesday said applications for its treatment for a type of asthma and chronic rhinosinusitis with nasal polyps, or CRSwNP, have been accepted for review in China, Japan and ...
Zacks.com on MSN2d
EMA Accepts GSK's Filing for Depemokimab in Two Respiratory DiseasesGSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...
which said it remains committed to brining the drug to patients with the inflammatory condition, which results in the growth of nasal polyps in the nose that can sometimes require surgical ...
Upstream Bio (NASDAQ:UPB – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Thursday, February 6th. Analysts expect Upstream Bio to post earnings of ...
Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...
Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback